原发性脾脏弥漫大B细胞淋巴瘤的临床病理分析
本研究评估了66例原发性脾脏弥漫大B细胞淋巴瘤和309例对照弥漫大B细胞淋巴瘤(非特指型)。原发脾脏组与对照组在丙型肝炎病毒抗体阳性率、B症状、体能状态差和CD5阳性方面存在显著差异。原发脾脏组按组织病理学分为白髓型(46例)和红髓型(20例),两组总生存无差异,但原发脾脏组无进展生存更优;红髓型总生存更差,CD5阳性为独立不良预后指标。
要点
- 原发脾脏DLBCL与对照DLBCL在HCV抗体、B症状、PS和CD5阳性率有显著差异。
- 白髓型与红髓型相比,红髓型总生存更差,CD5阳性率更高,PS更差。
- CD5阳性是原发脾脏DLBCL总生存的独立不良预后指标。
核心结论
- 原发脾脏DLBCL与对照DLBCL总生存无差异,但无进展生存更优;红髓型总生存更差,CD5阳性提示不良预后。
研究设计与样本
- 评估66例原发脾脏DLBCL和309例对照DLBCL(非特指型),对照DLBCL非特指型。
主要发现
- 原发脾脏DLBCL组与对照组在HCV抗体阳性率、B症状、体能状态差(2-4)和CD5阳性方面差异显著。
- 原发脾脏DLBCL分为白髓型(46例)和红髓型(20例)。
- 原发脾脏DLBCL与对照组总生存无差异,但原发脾脏DLBCL无进展生存更优。
- 白髓型与红髓型相比,白髓型与较低体能状态(2-4)和较低CD5阳性率相关;红髓型总生存更差。
- 多变量分析显示CD5阳性是原发脾脏DLBCL总生存的不良预后指标。
关键数值与推荐
- 原发脾脏DLBCL按组织病理学分为白髓型(n=46)和红髓型(n=20)。
- 白髓型与红髓型相比,白髓型与较低体能状态(2-4)和较低CD5阳性率相关。
- 红髓型总生存更差,CD5阳性是原发脾脏DLBCL总生存的不良预后指标。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Splenic infiltration is often seen in diffuse large B-cell lymphoma (DLBCL). However, primary splenic DLBCL is rare and studies on its clinicopathological features are limited. We assessed 66 cases of primary splenic DLBCL and 309 control DLBCL, not otherwise specified. Hepatitis C virus antibody prevalence, B symptoms, poor performance status and CD5 positivity differed significantly between the primary splenic DLBCL and control DLBCL groups. Primary splenic DLBCL cases were classified histopathologically into two groups [white pulp pattern (n = 46), red pulp pattern (n = 20)]. Survival analysis showed no difference in overall survival between the primary splenic DLBCL and the control group, but the former had a more favourable progression-free survival. In the examination of primary splenic DLBCL, the white pulp pattern was statistically associated with a lower performance status (2-4), and a lower CD5 positivity than the red pulp pattern. In the survival analysis, the red pulp pattern demonstrated poorer overall survival. Multivariate analysis of overall survival in primary splenic DLBCL cases identified CD5 positivity as an indicator of poor prognosis. Classifying primary splenic DLBCL into white and red pulp patterns was useful in terms of clinicopathological features and overall survival.
引用
- Shimono J, Miyoshi H, Kiyasu J, et al. Clinicopathological analysis of primary splenic diffuse large B-cell lymphoma. Br J Haematol. 2017. PMID: 28493517. doi:10.1111/bjh.14736
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。